BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 35846075)

  • 1. MicroRNAs as prognostic markers and therapeutic targets in gliomas.
    Sufianov A; Begliarzade S; Ilyasova T; Liang Y; Beylerli O
    Noncoding RNA Res; 2022 Sep; 7(3):171-177. PubMed ID: 35846075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs Regulate Cell Cycle and Cell Death Pathways in Glioblastoma.
    Sati ISEE; Parhar I
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as potential diagnostic markers of glial brain tumors.
    Sufianov A; Begliarzade S; Ilyasova T; Xu X; Beylerli O
    Noncoding RNA Res; 2022 Dec; 7(4):242-247. PubMed ID: 36203525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
    J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of micro-RNA in the regulation of signal pathways in gliomas].
    Kit OI; Vodolazhsky DI; Rostorguev EE; Porksheyan DH; Panina SB
    Biomed Khim; 2017 Nov; 63(6):481-498. PubMed ID: 29251609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Analyses.
    Wei X; Zhang QM; Liu C; Wu S; Nong WX; Ge YY; Lin LN; Li F; Xie XX; Luo B
    Curr Med Sci; 2022 Jun; 42(3):584-596. PubMed ID: 35678909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review.
    Ahir BK; Ozer H; Engelhard HH; Lakka SS
    Crit Rev Oncol Hematol; 2017 Dec; 120():22-33. PubMed ID: 29198335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propolis Extract Regulates microRNA Expression in Glioblastoma and Brain Cancer Stem Cells.
    C Yilmaz U; Bagca BG; Karaca E; Durmaz A; Durmaz B; Aykut A; Kayalar H; Avci CB; Susluer SY; Pariltay E; Gunduz C; Cogulu O
    Anticancer Agents Med Chem; 2022; 22(2):378-389. PubMed ID: 33949939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
    Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A
    Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum microRNAs as potential noninvasive biomarkers for glioma.
    Yu X; Li Z
    Tumour Biol; 2016 Feb; 37(2):1407-10. PubMed ID: 26628296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs in Human Malignant Gliomas.
    Mizoguchi M; Guan Y; Yoshimoto K; Hata N; Amano T; Nakamizo A; Sasaki T
    J Oncol; 2012; 2012():732874. PubMed ID: 22848219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy.
    Nikaki A; Piperi C; Papavassiliou AG
    Expert Opin Investig Drugs; 2012 Oct; 21(10):1475-88. PubMed ID: 22809292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA Multiplayers in glioma. From bench to bedside.
    Rolle K
    Acta Biochim Pol; 2015; 62(3):353-65. PubMed ID: 26307768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of microRNAs in human glioblastoma.
    Mizoguchi M; Guan Y; Yoshimoto K; Hata N; Amano T; Nakamizo A; Sasaki T
    Front Oncol; 2013; 3():19. PubMed ID: 23403472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of microRNA in the pathogenesis of glial brain tumors.
    Beylerli O; Gareev I; Sufianov A; Ilyasova T; Zhang F
    Noncoding RNA Res; 2022 Jun; 7(2):71-76. PubMed ID: 35330864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Glioblastoma Patients' Plasma Revealed the Presence of MicroRNAs with a Prognostic Impact on Survival and Those of Viral Origin.
    Herman A; Gruden K; Blejec A; Podpečan V; Motaln H; Rožman P; Hren M; Zupančič K; Veber M; Verbovšek U; Lah Turnšek T; Porčnik A; Koršič M; Knežević M; Jeras M
    PLoS One; 2015; 10(5):e0125791. PubMed ID: 25950799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of microRNA expression profile in malignant glioma tissues.
    Piwecka M; Rolle K; Belter A; Barciszewska AM; Żywicki M; Michalak M; Nowak S; Naskręt-Barciszewska MZ; Barciszewski J
    Mol Oncol; 2015 Aug; 9(7):1324-40. PubMed ID: 25864039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Circulating microrPas as new potential biomarkers for the diagnosis of high-grade gliomas].
    Gareev IF; Novicova LB; Beylerli OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(5):86-90. PubMed ID: 31317895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic risk model construction and molecular marker identification in glioblastoma multiforme based on mRNA/microRNA/long non-coding RNA analysis using random survival forest method.
    Wang H; Liu D; Yang J
    Neoplasma; 2019 May; 66(3):459-469. PubMed ID: 30784292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators.
    Daoud AZ; Mulholland EJ; Cole G; McCarthy HO
    BMC Cancer; 2019 Nov; 19(1):1130. PubMed ID: 31752758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.